This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Kewpie Corporation, Tokyo University of Marine Science and Technology. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2021
Title: Miki Sato: Innovator in Norovirus Deactivation
Introduction
Miki Sato is a prominent inventor based in Fukaya, Japan. She has made significant contributions to the field of virology, particularly in the development of methods for deactivating norovirus. Her innovative work has led to the creation of a patent that addresses critical health concerns related to norovirus infections.
Latest Patents
Miki Sato holds a patent for a norovirus deactivator and methods for producing the same. This patent includes various methods for deactivating norovirus, producing a lysozyme component for norovirus deactivation, and developing prophylactic or therapeutic agents for norovirus infections. The invention features a norovirus deactivator that incorporates a lysozyme component, which includes at least one kind selected from lysozyme and/or a salt thereof, along with a denatured product thereof. This innovative approach aims to provide effective solutions for norovirus deactivation, enhancing public health safety.
Career Highlights
Throughout her career, Miki Sato has worked with esteemed institutions, including the Tokyo University of Marine Science and Technology and Kewpie Corporation. Her experience in these organizations has allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.
Collaborations
Miki has collaborated with notable colleagues such as Hajime Takahashi and Takashi Miyashita. These partnerships have played a crucial role in advancing her research and the development of her patented technologies.
Conclusion
Miki Sato's innovative work in norovirus deactivation showcases her dedication to improving public health through scientific advancements. Her contributions are vital in the ongoing fight against viral infections, and her patent reflects her commitment to finding effective solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile